The influence of anti-inflammatory drugs on the proliferation of fibroblast derived from nasal polyps

Auris Nasus Larynx

Volumn 32, Issue 3, 2005, Pages 225-229

  Beata, Rostkowska Nadolska ^a   Wojciech, Fortuna ^b   Stanisław, Szymaniec ^b   Ryszard, Miȩdzybrodzki ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Budesonide; COX 1 inhibitors; COX 2 inhibitors; Fibroblasts; Nasal polyps; Proliferation

Indexed keywords

ANTIINFLAMMATORY AGENT; BUDESONIDE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; IBUPROFEN; NIMESULIDE; ROFECOXIB; THYMIDINE; TRITIUM;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; INFLAMMATORY INFILTRATE; NOSE POLYP;

ANTI-INFLAMMATORY AGENTS; BUDESONIDE; CELL PROLIFERATION; CELLS, CULTURED; FIBROBLASTS; HUMANS; IBUPROFEN; LACTONES; NASAL POLYPS; SULFONAMIDES; SULFONES;

EID: 23044467709     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2005.03.001     Document Type: Article

References (37)

1. M. Kitarjiri, N. Kubo, K. Tomoda, N. Maeda, T. Yamashita, and T. Kumazawa Sympathetic nerve disturbances and fine structure of adrenergic nerve terminals in nasal mucosa after experimentally-induced nasal hypersensivity Acta Otolaryngol Suppl 506 1993 47 50
2. K. Larsen, and M. Tos Clinical course of patients with primary nasal polyps Acta Otolaryngol (Stockh) 114 1994 556 559
3. G.A. Settipane Nasal polyps: epidemiology, pathology, immunology and treatment Am J Rhinol 1 1987 119 126
4. J.M. Bernstein, J. Gorfien, and B. Noble Role of allergy in nasal polyposis: a review Otolaryngol Head Neck Surg 113 1995 724 732
5. R. Pawankar Nasal polyposis: an update: editorial review Curr Opin Allergy Clin Immunol 3 2003 1 6
6. N. Bruzzese, G. Sica, F. Iacopino, G. Paludetti, D. Schiavino, and E. Nucera Growth inhibition of fibroblasts from nasal polyps and normal skin by lysine acetylsalicylate Allergy 53 1998 431 434
7. J. Ostwald, S. Graumuller, S. Dommerich, and M. Hoff Verhalten von Fibroblasten aus Nasenpolypen in Zelikultur nach Applikation ublicher Rhinologica und unublicher Medikamente unterschiedlicher Wirkstoffgruppen Laryngol Rhinol Otol 82 2003 408 415
8. Z. Xing, M. Jordana, T. Braciak, T. Ohtoshi, and J. Gauldie Lipopolysaccharide induces expression of granulocyte/macrophage colony-stimulating factor, interleukin-8, and interleukin-6 in human nasal, but not lung fibroblasts: evidence for heterogeneity within the respiratory tract Am J Respir Cell Mol Biol 9 1993 255 263
9. F. Saji, M. Nonaka, and R. Pawankar Expression of RANTES by IL-1 beta and TNF-alfa stimulated nasal polyp fibroblasts Auris Nasus Larynx 27 2000 247 252
10. C. Bachert, M. Wagenmann, U. Hauser, and C. Rudack IL-5 synthesis is upregulated in human nasal polyp tissue J Allergy Clin Immunol 99 1997 837 842
11. D.L. Hamilos, D.Y. Leung, D.P. Huston, A. Kamil, R. Wood, and Q. Hamid GM-CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP) Clin Exp Allergy 28 1998 1145 1152
12. C.H. Lee, C.S. Rhee, and Y.G. Min Cytokine gene expression in nasal polyps Ann Otol Rhinol Laryngol 107 1998 665 670
13. J.S. Allen, R. Eisma, G. Leonard, and D. Kreutzer Interleukin-3, interleukin-5, and GM-CSF expression in nasal polyps Am J Otolaryngol 18 1997 239 246
14. J. Bartels, S. Maune, J.E. Meyer, R. Kulke, C. Schluter, and J. Rowert Increased eotaxin-mRNA expression in non-atopic and atopic nasal polyps: comparison to RANTES and MCP-3 expression Rhinology 35 1997 171 174
15. J. Mullol, A. Xaubet, and A. Gaya Cytokine gene expression and release from epithelial cells. A comparison study between healthy nasal mucosa and nasal polyps Clin Exp Allergy 25 1995 606 615
16. J.E. Meyer, I. Berner, L.M. Teran, J. Bartels, M. Sticherling, and J.-M. Schroder Rantes production by cytokine stimulation nasal fibroblasts: its inhibition by glucocorticoids Int Arch Allergy Immunol 117 1998 60 67
17. F. Cagnoni, S. Oddera, C. Semino, M. Mincarini, G. Melioli, and G.W. Canonica Cetirizine induced downregulation of airway fibroblast proliferation and function: a rationale for a different approach to allergy treatment Immunol Lett 72 2000 31 34
18. L. Badia, and V. Lund Topical corticosteroids in nasal polyposis Drugs 61 5 2001 573 578
19. K.D. Nguyen, and D.A. Lee In vitro evaluation of antiproliferative potential of topical cyclooxygenase inhibitors in human Tenon's fibroblast Exp Eye Res 57 1993 97 105
20. B. Umbach, and V. Hennebach Changes in connective tissue metabolism in fibroblasts from nasal polyps HNO 42 1994 344 349
21. T. Nakagawa, H. Yamane, Y. Nakai, T. Shigeta, T. Takashima, and Z. Takeda Comparative assessment of cell proliferation and accumulation of extracellular matrix in nasal polyps Acta Otolaryngol 538 Suppl. 1998 205 208
22. N. Kusunoki, R. Yamazaki, and S. Kawai Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors Arthritis Rheum 46 2002 3159 3167
23. E. Castano, R. Bartrons, and J. Gil Inhibition of cyclooxygease-2 decreases DNA synthesis induced by platelet-derived growth factor in Swiss 3T3 fibroblasts J Pharmacol Exp Ther 293 2000 509 513
24. C.Y. Yang, C.L. Meng, C.L. Liao, and P.Y. Wong Regulation of cell growth by selective COX-2 inhibitors in oral carcinoma cell lines Prostaglandins Other Lipid Mediat 72 2003 115 130
25. J.A. Di Battista, H. Fahmi, Y. He, M. Zhang, J. Martel-Pelletier, and J.-P. Pelletier Differential regulation of interleukin-1β-induced cyclooxygenase-2 gene expression by nimesulide in human synovial fibroblasts Clin Exp Rheumatol 19 Suppl. 22 2001 53 55
26. G.M. Saed, A.R. Munkarah, and M.P. Diamond Cyclooxygenase-2 expressed in human fibroblasts isolated from peritoneal adhesions but not from peritoneal tissues Fertil Steril 79 6 2003 140 408
27. M. Falkowski, S. Skogstad, S. Shahzidi, B. Smedsrod, and K. Sveinbjornsson The effect of cyclooxygenase inhibitor diclofenac on experimental murine colon carcinoma Anticancer Res 38 2003 2303 2308
28. M. Nonaka, R. Pawankar, S. Tomiyama, and T. Yagi A macrolide antibiotic, roxitromycin, inhibits the growth of nasal polyp fibroblast Am J Rhinol 13 1999 267 272
29. D.L. Mattey, E. Evans, and P.T. Dawes The effects of Tenidap on cytokine induced proliferation of human synovial fibroblasts in vitro Ann Rheum Dis 53 1994 250 255
30. J. Grzegorczyk, M.L. Kowalski, T. Kornatowski, and R. Pawliczak Expression of cyclooxygenase in nasal polyps from atopic and nonatopic subjects J Investig Allergol Clin Immunol 9 1999 380 385
31. C.B. Yun, B.H. Lee, and T.J. Jang Expression glucocorticoid receptors and cyclooxygenase-2 in nasal polyps from nonallergic patients Ann Otol Rhinol Laryngol 111 2002 61 67
32. P. Demoly, L. Crampette, B. Lebel, A.M. Campbell, M. Mondain, and J. Bousquet Expression of cyclo-oxygenase 1 and 2 proteins in upper respiratory mucosa Clin Exp Allergy 28 1998 278 283
33. J. Gosepath, J. Brieger, E. Gletsou, and W.J. Mann Expression and localization of cyclooxigenases (COX-1 and COX-2) in nasal respiratory mucosa. Does COX-2 play a key role in the immunology of nasal polyps? J Investig Allergol Clin Immunol 14 2004 114 118
34. S. Bavbek, G. Celik, F. Ozer, D. Mungan, and Z. Misirligil Safety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drug-intolerant patients: comparison of nimesulide, meloxicam, and rofecoxib J Asthma 41 2004 67 75
35. A.M. Vignola, and V. Bellia Transcriptional regulation of COX-2: a key mechanism in the pathogenesis of nasal polyposis in aspirin-sensitive asthmatics? Allergy 58 2003 122 126
36. C. Picado, J.C. Fernandez-Morata, M. Juan, J. Roca-Ferrer, M. Fuentes, and A. Xaubet Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics Am J Respir Crit Care Med 160 1 1999 291 296
37. X. Zhang, S.G. Morham, R. Langenbach, and D.A. Young Malignant transformation and neoplastic action of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts J Exp Med 16 190 1999 451 459